Evidence map›Paper›PMID 16672722›Full record

ArticleBiology of reproduction2006

Vascular endothelial growth factor and kinase domain region receptor are involved in both seminiferous cord formation and vascular development during testis morphogenesis in the rat.

Rebecca C Bott, Ryann M McFee, Debra T Clopton, Candice Toombs, Andrea S Cupp

Open access · bronzeAbstract read
In one paragraph

Article in Biology of reproduction, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 107 citations in OpenAlex.

  1. Trial
  2. Article
  3. Defects in the H3t Gene Cause an Increase in Leydig Cells With Impaired Spermatogenesis in Mice.Genes to cells : devoted to molecular & cellular mechanisms · 2025
    Article
  4. Article
  5. Review
  6. Fetal Leydig cells: What we know and what we don't.Molecular reproduction and development · 2024
    Review
  7. Review
  8. A role for TRPC3 in mammalian testis development.Frontiers in cell and developmental biology · 2024
    Article
  9. Article
  10. Article
  11. International journal of molecular sciences · 2023
    Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Rebecca C BottDepartment of Animal Science, University of Nebraska-Lincoln, Lincoln, Nebraska 68583-0908, USA.
Ryann M McFee
Debra T Clopton
Candice Toombs
Andrea S Cupp
University of Nebraska–Lincoln · US

Funding

Role of VEGF in Testis Development and FunctionR03HD041546 · NICHD · UNIVERSITY OF NEBRASKA LINCOLN · PI CUPP, ANDREA S · 2003 to 2004
$142k
NICHD NIH HHS R03 HD041546NICHD NIH HHS R03 HD41546
6 · The paper itself

Abstract

Morphological male sex determination is dependent on migration of endothelial and preperitubular cells from the adjacent mesonephros into the developing testis. Our hypothesis is that VEGFA and its receptor KDR are necessary for both testicular cord formation and neovascularization. The Vegfa gene has 8 exons with many splice variants. Vegfa120, Vegfa164, and Vegfa188 mRNA isoforms were detected on Embryonic Day (E) 13.5 (plug date=E0) in the rat. Vegfa120, Vegfa144, Vegfa164, Vegfa188, and Vegfa205 mRNA were detected at E18 and Postnatal Day 3 (P3). Kdr mRNA was present on E13.5, whereas Fms-like tyrosine kinase 1 receptor (Flt1) mRNA was not detected until E18. VEGFA protein was localized to Sertoli cells at cord formation and KDR to germ and interstitial cells. The VEGFA signaling inhibitors SU1498 (40 microM) and VEGFR-TKI (8 microM) inhibited cord formation in E13 testis cultures with 90% reduced vascular density (P<0.01) in VEGFR-TKI-treated organs. Furthermore, Je-11 (10 microM), an antagonist to VEGFA, also perturbed cord formation and inhibited vascular density by more than 50% (P<0.01). To determine signal transduction pathways involved in VEGFA's regulation of testis morphogenesis, E13 testis were treated with LY 294002 (15 microM), a phosphoinositide 3-kinase (PI3K) pathway inhibitor, resulting in inhibition of both vascular density (46%) and cord formation. Thus, we support our hypothesis and conclude that VEGFA, secreted by the Sertoli cell, is involved in both neovascularization and cord formation and potentially acts through the PI3K pathway during testis morphogenesis to elicit its effects.

Indexed as

Neovascularization, PhysiologicAnimalsChromonesEnzyme InhibitorsMaleMorphogenesisMorpholinesOrgan Culture TechniquesPhosphoinositide-3 Kinase InhibitorsProtein IsoformsRatsSeminiferous TubulesSignal TransductionTestisVascular Endothelial Growth Factor AVascular Endothelial Growth Factor Receptor-22-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-oneChromonesEnzyme InhibitorsMorpholinesPhosphoinositide-3 Kinase InhibitorsProtein IsoformsVascular Endothelial Growth Factor Avascular endothelial growth factor A, mouseVascular Endothelial Growth Factor Receptor-2

Identifiers

PMID16672722
PMCPMC2366204
OpenAlexW2152050999

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.